Milestone Pharmaceuticals

InCarda Therapeutics

This biopharmaceutical company develops inhaled therapies to treat patients with acute cardiovascular conditions such as paroxysmal atrial fibrillation.

Cardurion Pharmaceuticals

This clinical-stage biotechnology company develops therapeutic drugs for patients with heart failure and other cardiovascular diseases.

ARS Pharmaceuticals

ARS Pharmaceuticals develops a needle-free nasal spray for patients and caregivers to treat severe allergic reactions, including anaphylaxis.

Miist Therapeutics

This company develops inhaled drug delivery devices providing rapid symptom relief for patients suffering from migraines or seeking smoking cessation.

NanoPhoria

This company develops an inhalable nano-drug delivery platform and therapeutics for patients with heart failure and other cardiovascular diseases.

IMPL

This biopharmaceutical company develops nasal spray treatments for central nervous system disorders, such as migraines and Parkinson's disease, for patients with high unmet needs.

Paratek Pharmaceuticals

This company develops and commercialises antibiotics and nasal sprays for patients with infectious diseases, pneumonia, skin infections and chronic rhinosinusitis.

Acesion Pharma ApS

This biotech company develops small-molecule drugs to treat atrial fibrillation by inhibiting ion channels for patients with cardiac arrhythmia.